WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced that shipments of COVID-19 molecular diagnostic tests reached one million per day for the week ending July 24, based on the latest data from the association's National Testing Registry.
You are here
WASHINGTON, D.C. – In its latest action to help ensure the widespread availability of testing to detect and contain the coronavirus, the Advanced Medical Technology Association (AdvaMed) today announced the creation of a comprehensive, national COVID-19 diagnostic supply registry to help state and federal governments in their pandemic responses. The national registry is being launched in partnership with 13 commercial diagnostics manufacturers: Abbott, BD, bioMérieux, Bio-Rad, Beckman Coulter, Cepheid, Hologic, Ortho Clinical Diagnostics, QIAGEN, Roche Diagnostics, Sekisui Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific.
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today released the following statement from Susan Van Meter, executive director of AdvaMedDx, in response to comments on COVID-19 serology/antibody testing at today’s hearing by the Economic & Consumer Policy Subcommittee of the House Committee on Oversight & Reform: